Drug Shortage Report for TEVA-PIROXICAM
Report ID | 42570 |
Drug Identification Number | 00695718 |
Brand name | TEVA-PIROXICAM |
Common or Proper name | PIROXICAM |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PIROXICAM |
Strength(s) | 10MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | M01AC |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-03-07 |
Estimated end date | 2018-03-21 |
Actual end date | 2018-04-15 |
Shortage status | Resolved |
Updated date | 2018-05-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-03-13 | English | Compare |
v2 | 2018-03-13 | French | Compare |
v3 | 2018-05-11 | English | Compare |
v4 | 2018-05-11 | French | Compare |
Showing 1 to 4 of 4